• Bribery,  Deferred Prosecution Agreements

    White-Collar Crime, DPAs and Repeat Business

    The phenomenon of extending corporate deferred-prosecution agreements (or “DPAs”) continues, as here with medical device maker Biomet, and controversy inevitably ensues: Life was supposed to return to normal for Biomet, the giant medical devices manufacturer accused of foreign bribery, when its federal probation expired next week. But on Tuesday, Biomet disclosed that prosecutors would extend its probation another year as they investigate new evidence of wrongdoing at the company, the Justice Department’s latest attempt to stem a widening pattern of corporate recidivism. The Department of Justice, however, has been clear recently: “Make no mistake: The criminal division will not hesitate to tear up a D.P.A. or N.P.A. and file criminal…